Purchased 3,530,000 shares of common stock in the April 2024 Private Placement at $8.50 per share.
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Peter Blume-Jensen
Also a director
Chief Executive Officer, President, and Chairman of the Board
|
64 | Not stated | $2,718,538 | |
|
Adam Levy
Chief Financial Officer
|
61 |
Since 2025
1 year
|
Not reported | |
|
Eric Devroe
Chief Operating Officer
|
48 |
Since 2022
4 years
|
$1,358,003 | |
|
Mary-Alice Miller
Chief Legal Officer
|
52 |
Since 2023
3 years
|
Not reported | |
|
Mansoor Raza Mirza
Chief Medical Officer
|
65 |
Since 2025
1 year
|
Not reported | |
|
Erick Gamelin
Chief Development Officer
|
69 |
Since 2024
2 years
|
Not reported | |
|
Michaela Levin
Chief Business Officer
Title from the Form 4 dated Aug 31, 2026
|
Not stated | Not stated | Not reported | |
|
Katharine Peterson
Chief Accounting Officer
Title from the Form 4 dated Aug 18, 2026
|
Not stated | Not stated | Not reported | |
|
Kristina Masson
Also a director
Executive Vice President, Business Operations, and Director
|
46 | Not stated | $1,424,926 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased 3,530,000 shares of common stock in the April 2024 Private Placement at $8.50 per share.
Purchased 2,353,000 shares of common stock in the April 2024 Private Placement at $8.50 per share.
Purchased 470,000 shares of common stock in the April 2024 Private Placement at $8.50 per share.
Purchased 470,000 shares of common stock in the April 2024 Private Placement at $8.50 per share.
Loading...